$LYNX

Morrison Brian sold $3.1M of LYNX

Morrison Brian (Chief Executive Officer) sold 186,752 shares of Lyntris Inc. (LYNX) at $16.45 ($3.07M total) on 2026-08-20.

Original reporting
SEC EDGAR · Morrison Brian
Published Aug 21, 2026, 9:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LYNX
Bearish
medium confidence
Mentioned
$LYNX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LYNXBearishLow
01

Why it matters

The CEO's sale reduces insider ownership, which may affect investor perception.

02

Market read

Insider sell is a modest negative catalyst for LYNX.

03

What to watch

No disclosed reason; could be personal financial planning.

Relevance 6/10Novelty 7/10Timing: post‑market 2026‑08‑21

Background

Form 4 filings disclose insider transactions; investors monitor them for signals.

Company-level read

Ticker impact

$LYNXBearishMedium confidence
Context

CEO Brian Morrison sold 186,752 shares for $3.07M, reducing his stake to 1.29M shares.

Expected impact

Modest downward pressure in short term.

Evidence & confidence

The sale size is material for a mid‑cap, but no other catalyst is present.

Market effects

Minimal impact on the broader biotech sector.

US market only.

Low

Counterpoint

The sale could be a routine liquidity move, not a negative signal.

Key entities

  • Lyntris Inc.

    Biotech firm listed on US exchange under ticker LYNX.

  • Brian Morrison

    Chief Executive Officer of Lyntris Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYNXHigh

Why is Lyntris stock surging today?

Lyntris Inc. (LYNX) stock rose 5.6% to $13.45 after five analysts initiated coverage with Buy or Outperform ratings and price targets of $18-$21, citing its defense tech growth potential. The broader market was down, making the gain company-specific. The stock had been near its 52-week low since a weak IPO in August.